Articles

• Cancer in Primary Immunodeficiency Diseases: An Overlooked Threat

  Sahar Mirzaee
• Efficacy and Safety of Small-Molecule Human Epidermal Growth Factor Receptor 2 (HER2)-Targeting Tyrosine Kinase Inhibitor-Containing Regimens for Metastatic HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical

  Amin Pastaki Khoshbin, Farzaneh Darbeheshti, Amin Doosti-Irani, Mahsa Keshavarz-Fathi, Mohammad Ali Mansournia
• Effectiveness of Immune Checkpoint Inhibitors in the Treatment of Colon Adenocarcinoma

  Rad Ghannadzadeh Kermani Pour, Sepideh Razi
• Adoptive Cell Therapy in Pediatric Leukemia

  Maryam Sadeghi, Kosar Asnaashar
• The Role of Immune Checkpoint Inhibitors in Brain Metastasis: a Comprehensive Review

  Melika Jameie, Fatemeh A Basti, Mobina Amanollahi, Arash Heidari
• HMGB1 Polymorphisms in Acute Lymphoblastic Leukemia

  Elham Rayzan, Saeed Farajzadeh Valilou, Sara Hemmati, Amin Sadeghi, Hamid Farajifard, Sepideh Shahkarami, Nima Rezaei
• Evaluation of Tumor Immune Microenvironment Changes in Response to Different Radiotherapy Regimens in a CT26 Tumor Model

  Masoumeh Alimohammadi, Haniyeh Ghaffari Nazari, Reza Alimohammadi, Mohsen Bakhshandeh, Seyed Amir Jalali, Nima Rezaei
• Breast Cancer-Associated Fibroblasts Could Induce the PI3K/Akt/ mTOR Signaling Pathway Through Downstream Long Non-Coding RNA HOTAIR

  Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Kamran Mansouri, Ali Mostafaie, Farshid Noorbakhsh, Sadaf Alipour, Foroozan Ghalkhani, Ramesh Omranipour, Seid-Shahram Miraghaee, Sarah Kiani, Nima Rezaei